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Abstract
Placental inflammatory response (PIR) is associated with adverse neonatal outcomes such as sepsis, cerebral palsy, low birth
weight, preterm birth, and neonatal mortality. However, there is an urgent need for noninvasive and sensitive biomarkers
for prediction of PIR. In this study, we evaluated the clinical usefulness of maternal serum inflammatory markers for
prediction of PIR in women with impending preterm birth. We conducted a retrospective cohort study of 483 patients who
delivered preterm neonates. Serum levels of leukocyte differential counts, C-reactive protein (CRP), and neutrophil to
lymphocyte ratio (NLR) were compared between women with no placental inflammation and women with PIR. The mean
neutrophil counts, CRP levels, and NLR in both the patients with histologic chorioamnionitis (HCA) alone and those with
HCA with funisitis were significantly higher than those in women with no placental inflammation. Compared to leukocyte
subset or CRP, NLR in women with funisitis was significantly higher than in women with HCA alone and showed higher
predictive accuracy, along with 71.4% sensitivity, 77.9% specificity, 80.7% positive predictive value, and 67.8% negative
predictive value for prediction of PIR. On Kaplan-Meier survival analysis, women with both an elevated level of CRP and a
high NLR had a shorter admission-to-delivery interval compared to women with either an elevated level of CRP or a high
NLR alone. NLR may be a predictive marker of PIR and could be used as a cost-effective parameter for identifying women at
risk of PIR.
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Introduction
Intrauterine inflammation is thought to be the principal
contributor to the onset of preterm parturition [1,2]. The
inflammatory responses of the placenta and umbilical cord, as
markers of intrauterine inflammation, have been classified as
maternal inflammatory response (MIR) and fetal inflammatory
response (FIR). While MIR occurs as inflammation infiltrates into
the chorion, amnion, or decidua, FIR occurs when the inflam-
mation is extended to the chorionic plate, umbilical cord, and fetal
vessels themselves and is defined as a fetal plasma Interleukin-6
concentration .11 pg/mL [3–5].
Histologic chorioamnionitis (HCA) is regarded as a hallmark of
maternal inflammation of the placenta, whereas funisitis, or
inflammation of the umbilical cord, is a marker of fetal
inflammation [4]. HCA is often present in the placentas of
patients who experience preterm labor or preterm premature
rupture of membranes (pPROM) [6]. Preterm infants from
mothers with HCA are at high risk of developing adverse neonatal
outcomes. Numerous published studies have addressed the impact
of HCA on neonatal sepsis, intraventricular hemorrhage, cerebral
white matter abnormalities, bronchopulmonary dysplasia, cerebral
palsy, and neonatal mortality [7–9]. Funisitis often represents FIR;
the presence of funisitis is related to a more advanced state of
intrauterine inflammation. FIR with extensive placental involve-
ment displays a wide spectrum of severity, and the additional
presence of FIR appears to exacerbate the detrimental effects of
chorioamnionitis on neonatal outcomes [5,10].
Therefore, prenatal diagnosis of placental inflammatory re-
sponse (PIR) is of great clinical importance in providing
information that may be useful in determining the prognosis and
treatment strategy for a pregnant woman and neonate at risk of
preterm birth. In this study, a noninvasive and rapid prenatal
HCA diagnostic method using a maternal serum marker was
developed, and the usefulness of the method as a predictive factor
for intrauterine inflammation was evaluated.
Materials and Methods
This retrospective study included data from 483 consecutive
patients who delivered preterm neonates at the Department of
Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei
University College of Medicine, between June 2007 and May
2013. We included patients who met the following criteria: (1)
singleton gestation, (2) Preterm delivery occurring between 24 and
37 weeks of gestation (3) spontaneous preterm births as a result of
preterm labor or pPROM (4) results available for histopathologic
examination of the placenta, (5) no history of cervical cerclage, (6)
no major congenital anomalies or intrauterine fetal death, and (7)
the absence of preexisting maternal or placental diseases. All study
participants signed a written informed consent and the protocol of
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this study was approved by the Institutional Review Board of
Gangnam Severance Hospital (IRB No. 3-2013-0131).
The clinical characteristics of the mothers and infants were
retrieved from a review of medical records. Maternal blood was
collected at the time of admission, prior to administration of
antibiotics, corticosteroids, or tocolytics. For all study subjects,
serum levels of leukocyte differential counts and C-reactive protein
(CRP) obtained at admission were collected retrospectively. The
neutrophil to lymphocyte ratio (NLR) was defined as the absolute
neutrophil count divided by the absolute lymphocyte count.
Additionally, vaginal swabs were taken from all study subjects for
detection of aerobic and anaerobic bacterial overgrowth, Candida
colonization, Ureaplasma urealyticum and Mycoplasma hominis
colonization at the time of admission. We also analyzed the
pregnancy outcomes of all study subjects to evaluate the clinical
significance of maternal inflammatory markers as a prognostic
marker. We defined pregnancy outcome as the time interval from
admission to delivery.
Histologic data were obtained by reviewing placental pathology
reports. In all cases, histologic examination of the placenta,
umbilical cord, and fetal membranes was performed. Paraffin-
embedded tissue blocks were sectioned and stained with hema-
toxylin and eosin (H&E). Placental inflammatory status was
classified based upon the following criteria: MIR was defined as
subchorionitis, chorioamnionitis, deciduitis, or free membranitis
without funisitis or chorionic plate vasculitis; FIR was defined as
inflammation extending to the fetal side of the placental unit
(funisitis or chorionic plate vasculitis). Only four women with FIR
in the absence of MIR were excluded from the subsequent
statistical analyses.
We performed the Shapiro-Wilk test for testing the normality of
data. Clinical characteristics and pregnancy outcomes were
compared using non-parametric test for continuous variables
and presented as the mean 6 standard deviation or mean (range).
Multiple comparisons among three groups were conducted by
Kruskal-Wallis test and differences between two groups were
assessed by Mann-Whitney U test with Bonferroni correction (p,
0.0167). Categorical variables were compared using Chi-square
test or Fisher’s exact test and presented as numbers (%).
Laboratory data was assessed by analysis of covariance (AN-
COVA) with gestational age as the covariate.
Receiver operating characteristic (ROC) analysis was used to
estimate the specificity and sensitivity of each marker. We
calculated the area under the curve (AUC), which indicates the
average sensitivity of a marker over the entire ROC curve, and
determined the optimal cut-off value resulting in the highest sum
of sensitivity and specificity for each marker. Survival plots were
drawn using the Kaplan-Meier method to evaluate the relation-
ship between pregnancy outcome and the result of each marker,
and the differences were calculated using the log-rank test.
Univariate and multivariate logistic regression analysis were
performed to evaluate independent prognostic factors associated
with PIR. For all analyses, a P,0.05 was considered statistically
significant except pair-wise comparison. Statistical analyses were
performed using SPSS version 17.0 (SPSS Inc., Chicago, IL).
Results
Clinical characteristics of the study population
The study population consisted of 483 patients who delivered
preterm neonates between June 2007 and May 2013. On placental
histologic examination of the study subjects, 59.4% (287/483) had
evidence of PIR. Among the 287 women with PIR, HCA alone
was observed in 85.7% (246/287), and combined HCA and
funisitis was identified in 14.3% (41/287). Table 1 shows the
clinical characteristics and pregnancy outcomes of the study
subjects according to the presence or absence of HCA and
funisitis. There were significant differences in antenatal cortico-
steroid use, gestational age at hospitalization and delivery,
neonatal intensive care unit admission, APGAR score at 1 and
5 minutes, and birth weight among the three groups. While MIR
and FIR were significantly more frequent in early preterm and
moderately preterm births, normal placenta was more frequent in
late preterm birth. These results showed that MIR and FIR are
more common placental pathological findings in the early preterm
and moderately preterm births and its frequency decreases with
advancing gestation.
Leukocyte differential counts, CRP, NLR, and vaginal
cultures
Leukocyte differential counts, CRP levels, NLR, and the results
of vaginal cultures are shown in Table 2. There were significant
differences in the mean neutrophil counts, mean lymphocyte
counts, and serum CRP levels among women with no placental
inflammation, HCA alone, and HCA with funisitis. The mean
neutrophil counts and CRP levels in both the patients with HCA
alone and those with HCA with funisitis were significantly higher
than those in women without any placental inflammation. The
lymphocyte counts in both the patients with HCA alone and those
with HCA with funisitis were significantly lower than those in
women without any placental inflammation. Because the neutro-
phil and lymphocyte counts in all HCA groups were significantly
different from those of women without HCA, we investigated the
diagnostic and prognostic significance of NLR. The NLR was
significantly higher in both women with HCA alone and in those
with HCA with funisitis than in women without any placental
inflammation, and differences could be distinguished among all
three groups; the NLR in women with funisitis was significantly
higher than that in women with HCA alone. With regard to CRP
levels, however, there was no difference between these two groups.
In addition, there were no differences in the results of vaginal
cultures, including U. urealyticum and M. hominis, among the
three groups.
Diagnostic significance of NLR in predicting PIR
Using ROC curve analysis, we compared the diagnostic indices
and predictive values of leukocyte differential counts, CRP levels,
and the NLR in predicting PIR (Table 3). The NLR had the
highest AUC value of 0.798 (95% CI, 0.756–0.841) with a cut-off
value of 6.48, and it had a sensitivity of 71.4%, specificity of
77.9%, positive predictive value (PPV) of 80.7%, and negative
predictive value (NPV) of 67.8% as a predictor for PIR. For CRP
levels, the AUC was 0.727 (95% CI, 0.679–0.776) with a cut-off
value of 7.46, along with 56.8% sensitivity, 82.9% specificity,
81.1% PPV, and 59.8% NPV. To categorize study subjects as
CRP and NLR positive or negative, an optimal cut-off value was
chosen to maximize the sum of sensitivity and specificity in the
ROC curve. We also assessed the effectiveness of the NLR as an
additional diagnostic marker to CRP levels for predicting PIR. In
women with PIR (n= 287), CRP-negative (,7.46 mg/L) status
was found in 124 (43.2%) of 287 patients. Of 124 patients with a
false negative in CRP levels, 65 (52.4%) were NLR positive ($
6.48), which could be used as an additional diagnostic marker of
PIR (Figure 1).
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Prognostic significance of NLR in pregnancy outcome
Figure 2 shows the Kaplan-Meier survival analysis for CRP
levels and the NLR. It reveals that CRP-positive ($7.46 mg/L)
women had a significantly shorter admission-to-delivery interval
than CRP-negative (,7.46 mg/L) women (median, 4 vs. 26 days;
log rank, P,0.001), and NLR-positive ($6.48) women had a
significantly shorter admission-to-delivery interval compared to
NLR-negative (,6.48) women (median, 6 vs. 24 days; log rank,
P,0.001). When the patients were classified into three groups
based on CRP levels and the NLR, patients with both an elevated
level of CRP and a high NLR had a shorter admission-to-delivery
interval compared to patients with either an elevated level of CRP
or a high NLR (Figure 3).
Relationship between clinical and laboratory parameters
and PIR
To assess the relative importance of demographic and clinical
characteristics in the prediction of PIR, we performed multiple
logistic regression analysis with variables to be considered risk
factors for PIR and clinical parameters (Table 4). Using the cut-off
values derived from the ROC curves, elevated levels of CRP ($
7.46 mg/L) and NLR ($6.48) were significantly associated with
PIR, even after controlling for gestational age at hospitalization
and delivery, monocytes, and ureaplasma infection.
Discussion
The principal findings of this study were as follows: 1) the NLR
had a better overall diagnostic performance than maternal serum
CRP levels in predicting PIR and distinguishing HCA from
funisitis; 2) patients with a high NLR were at risk of impending
preterm delivery in the context of normal CRP levels; and 3) the
combined use of NLR and CRP levels measured before treatments
can predict poor pregnancy outcomes in patients with PIR.
In general, amniotic fluid analysis and histologic examination of
the placenta are important methods of diagnosing intrauterine
inflammation. The examination includes gram staining of the
amniotic fluid and measurement of leukoattractants, glucose
concentration, white blood cell count, and interleukin 6 (IL-6)
[11,12]. However, an important limitation of these examination
methods is that amniocentesis, an invasive procedure, is unavoid-
able. In addition, diagnosis of HCA through histologic examina-
tion of the placenta is possible only after delivery; thus, the method
is not suited for rapid prenatal diagnosis of intrauterine
inflammation, nor can it be used in neonatal treatment in patients
Figure 1. Comparison of neutrophil to lymphocyte ratio (NLR) (y-axis) and C-reactive protein (CRP) (x-axis) in placental
inflammatory response group (red open circle) and control group (green filled triangle). The dotted lines indicate the optimal cut-off
values (6.48) of NLR and CRP (7.46) which maximize the sum of sensitivity and specificity.
doi:10.1371/journal.pone.0107880.g001
Table 3. Diagnostic indices of leukocyte differential counts, CRP and NLR in study subjects.
AUC (95% CI) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Cutoff Value
Neutrophil 0.706 (0.656–0.755) 49.6 85.6 81.7 56.8 10865
Lymphocyte 0.348 (0.296–0.401) 49.6 28.2 47.2 30.2 1235
Monocyte 0.541 (0.485–0.597) 72.2 36.5 59.5 50.4 365
Basophil 0.488 (0.432–0.544) 8.5 94.5 66.7 44.4 65
Eosinophil 0.473 (0.417–0.529) 3.4 99.4 88.9 44.3 350
CRP 0.727 (0.679–0.776) 56.8 82.9 81.1 59.8 7.46
NLR 0.798 (0.756–0.841) 71.4 77.9 80.7 67.8 6.48
AUC, area under the curve; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; CRP, C-reactive protein; NLR, neutrophil to lymphocyte
ratio.
doi:10.1371/journal.pone.0107880.t003
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diagnosed with neonatal sepsis. Therefore, many researchers have
attempted to develop a prenatal, noninvasive, and rapid method of
diagnosing intrauterine inflammation. Noninvasive diagnostic
tools used to assess the risk of HCA include measurement of
maternal serum CRP levels and leukocyte counts, but these
conventional infection markers, when used alone, have poor
diagnostic value in distinguishing patients with HCA from those
with no placental inflammation.
Because the physiological immune response of circulating
leukocytes to systemic inflammation is accompanied by increased
neutrophils and decreased lymphocytes, the NLR has been
proposed as a simple parameter of systemic inflammation and
stress in various diseases [13–15]. Earlier, we had already shown
that a combined marker, including the NLR, provided a more
sensitive parameter than the cervix length alone in the prediction
of preterm birth [16]. Given that HCA has been shown to be
Figure 2. Kaplan-Meier overall survival of admission-to-delivery intervals according to C-reactive protein (CRP) (a) and neutrophil to
to lymphocyte ratio (NLR) (b). CRP-positive ($7.46), NLR-positive ($6.48), dotted line; CRP-negative (,7.46), NLR-negative (,6.48), broken line.
doi:10.1371/journal.pone.0107880.g002
Figure 3. Kaplan-Meier overall survival of admission-to-delivery intervals according to C-reactive protein (CRP) levels and
neutrophil to lymphocyte (NLR) status.
doi:10.1371/journal.pone.0107880.g003
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associated with increased blood levels of inflammatory markers, we
hypothesized that the NLR should be affected during the
inflammatory processes of HCA.
The present study showed that an increased NLR is an
appropriate indicator for prenatal diagnosis of HCA. According to
the ROC curve analysis, maternal NLR at the time of admission
has greater diagnostic usefulness than CRP level with regard to
acute HCA and may serve as a useful marker to distinguish HCA
with funisitis from HCA without funisitis. Our results showed that
intrauterine inflammation may be prenatally predicted even
without the use of an invasive diagnostic method such as
amniocentesis. Moreover, we investigated whether combined use
of CRP level and NLR, measured before treatment, can predict
poor pregnancy outcomes in patients with PIR. We observed
significant prognostic differences among patients having both a
normal CRP level and a low NLR, those with either an elevated
level of CRP or a high NLR, and those with both an elevated level
of CRP and a high NLR. These results indicate that the
combination of CRP level and NLR may help to improve
prognostic accuracy in patients with PIR. Although the NLR is
limited in providing all necessary information as a predictive
marker, it can still complement other inflammatory markers in
predicting HCA. In addition, a mother experiencing preterm
labor in whom the NLR is increased at the time of admission may
have a high possibility of preterm birth due to the failure of
suppression of uterine contraction, and she may subsequently have
a poor pregnancy outcome, with delivery taking place in a shorter
time interval from admission compared to a pregnant woman in
whom the NLR is not high. Our multivariable logistic regression
analysis showed that the NLR may independently predict PIR,
without being affected by other factors, providing evidence that it
is a very useful test in predicting the prognosis of pregnancy.
It was assumed that the cytokines and chemokines secreted from
the partial inflammatory lesion in the choriodecidua generated
during the early stage of intrauterine inflammation may enter the
blood of a pregnant woman and cause changes in the counts of
leukocyte subtypes [17,18]. A strong host immune response that
results from an increase in the local production of proinflamma-
tory cytokines and chemokines such as IL-1b, IL-6, IL-10, tumor
necrosis factor-a (TNF-a), granulocyte colony-stimulating factor
(G-CSF), prostaglandins, and leukotrienes eventually allows
neutrophilia to occur [19]. Lymphopenia, on the other hand,
results from inflammation-induced mechanisms such as impaired
antigen presentation, activated negative costimulatory signals, and
production of immunosuppressive factors, all of which can
contribute to a significant decrease in T-helper lymphocytes
[20]. In the early phase of the inflammatory response, the TNF
family members are induced, thus increasing both the expression
of receptors on lymphocytes and also lymphocyte apoptosis. This
phenomenon occurs primarily because the protective lymphocyte-
dependent immune responses are reduced by marked decreases in
lymphocytes [21,22].
Numerous studies have attempted to identify useful biomarkers
for HCA through the analyses of amniotic fluid and maternal
blood [11,23–25]. CRP, produced by the liver as an acute phase
protein, is a nonspecific marker generated in response to
inflammatory stimuli. As one of many major laboratory tests,
CRP is primarily used when an obstetrician needs to monitor
various inflammatory conditions such as chorioamnionitis [24].
However, according to recent systemic reviews and a meta-
analysis conducted by Lamont’s group, maternal serum CRP may
not be considered a reliable indicator of either clinical or histologic
chorioamnionitis due to the presence of differences among studies
[26]. In addition, Romero et al. [6] reported correlations among
the existence of a placental inflammatory lesion, inflammation
level, and choriodecidua inflammation pattern via amniotic fluid
culture results and amniotic fluid white blood cell counts,
respectively. Although HCA and amniotic fluid culture tests are
useful in diagnosing intrauterine inflammation and predicting the
prognosis of a neonate, they have drawbacks, such as the time
needed for culture and the high possibility of a false negative result
due to various causes. Furthermore, Romero et al. [27] and Yoon
et al. [11] reported that IL-6 concentration in amniotic fluid is a
more sensitive measure for predicting intrauterine inflammation
than gram staining, the glucose concentration, or the white blood
cell count of amniotic fluid. Among various cytokines, many
studies in the past investigated IL-6, as it could be measured
relatively easily. However, with recent developments in measure-
ment methods, various cytokines such as IL-1b, IL-8, TNF-a,
matrix metalloproteinase-8, 9 (MMP-8, 9), and IL-1 receptor
agonist are now being further measured. The method of
measuring the cytokine concentration in amniotic fluid appears
very promising, having achieved particularly high sensitivity and
specificity. However, this method is not widely performed because
it is relatively difficult in practice and the cost is high.
Importantly, in our study, the NLR performed significantly
better than either CRP level or neutrophil counts in the prediction
of PIR, although these last two markers are used widely in the
Table 4. Adjusted risk factors for PIR in patients with preterm delivery.
Risk factor Adjusted odds ratio (95% CI) P
Gestational age at admission
,28 1.72 (0.31–9.48) 0.532
28–32 0.52 (0.17–1.58) 0.248
.33 1 (referent)
Gestational age at delivery
,28 2.85 (0.46–17.52) 0.259
28–32 2.77 (0.89–8.61) 0.078
.33 1 (referent)
CRP.7.46 3.40 (1.83–6.34) ,0.001
NLR.6.48 5.18 (2.95–9.10) ,0.001
PIR, placental inflammatory response; CI, confidence interval; CRP, C-reactive protein; NLR, neutrophil to lymphocyte ratio.
doi:10.1371/journal.pone.0107880.t004
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diagnosis of HCA. As demonstrated in this study and described in
our previous studies, maternal blood NLR may be considered the
most useful, noninvasive prenatal diagnostic method currently
known. Measuring the NLR in a pregnant woman experiencing
preterm labor or pPROM may reduce the frequency of
unnecessary amniocentesis to as low a level as possible. Moreover,
measuring the NLR has other advantages, such as that the test
sample may be simply obtained and the NLR may be easily
measured using conventional facilities, without the need of
additional instruments or reagents.
This study is the first to ever examine and report an
independent diagnostic and prognostic value of measuring
maternal serum NLR for HCA and funisitis. The limitation of
this study, however, is its retrospective design and the results here
should, ideally, be confirmed by subsequent larger prospective
studies. Furthermore, since we used a single blood sample to
calculate NLR, it is uncertain whether a single sample could reflect
an elevated NLR over time.
In conclusion, however, the significance of this study is that it
showed that a placental inflammatory change may be simply and
quickly verified at low expense by measuring the NLR. Further
studies may still be needed to explore whether injecting an
antibiotic in a pregnant woman with an increased NLR may
reduce various neonatal complications and various sequelae of
neonates accompanying histologic chorioamnionitis.
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